Skip to main content
. 2020 Nov 23;9(11):2522. doi: 10.3390/cells9112522

Table 2.

Antibodies specifications and working solutions used in this study.

Target m/pAb Specie Source Cat. Number Dilution Assay
LIMD2 1 pAb Rabbit Peng et al. [8] - 1: 1000 WB
LIMD2 2 pAb Rabbit Abcam Ab221110 1:33 WB, HCS
Α-tubulin mAb Mouse Sigma-Aldrich T9026 1:10,000 WB
F-actin 3 - - Thermo Fisher Scientific A12379 1:300 HCS
Histone-γH2AX pAb Rabbit Novus Biologicals NB100-384 1:100 FC
P53 pAb Rabbit Abcam ab131442 1:100 FC
β-catenin mAb Mouse Santa Cruz Biotechnology Sc-376841 1:100 FC, HCS
STAT3 (Y705) pAb Rabbit R&D Systems AF4607 1:100 FC, HCS
STAT5α mAb Mouse Santa Cruz Biotechnology Sc-166479 1:200 FC, HCS
SLUG pAb Rabbit Santa Cruz Biotechnology sc-15391 1:100 FC, HCS
TWIST2 mAb Mouse Abcam Ab50887 1:50 FC, HCS
N-cadherin mAb Mouse Dako M3613 1:100 FC, HCS
FITC-conjugated goat anti-rabbit IgG pAb Goat Thermo Fisher Scientific AB42978 1:1000 FC, HCS
FITC-conjugated goat anti-mouse IgG pAb Goat Thermo Fisher Scientific AB2533946 1:10,000 FC, HCS

WB, Western blot; FC, flow cytometry; HCS, high-content screening. 1 LIMD2 antibody developed by Peng et al. [8] was used to screen the LIMD2 expression in cell lines derived from different histological types of thyroid cancer. This antibody is now commercialized by Merck (MABC1168) and recognizes the full-length human LIMD2. 2 LIMD2 antibody Ab221110 was used to confirm the LIMD2 knockout in both edited cells, since it recognized the amino acid residues 105–126 (C-terminal region) comprised within the edited region. 3 F-actin was detected using the FITC-conjugated phalloidin mycotoxin.